Appendix 4D and Half Year Report
Filed with ASX · · 22 pages · English
Provided below are the Results for Announcement to the Market in accordance with ASX Listing Rule 4.2A and Appendix 4D for EVE Health Group Limited and its controlled entities for the period ended 31 December 2025 (the reporting period) compared with the period ended 31 December 2024 (the prior period). $ Net tangible assets per security The net tangible assets per ordinary security is $0.0027 (31
EVE Health Group Limited on 6ix
Earlier from EVE Health
- Launch of Libbo and Activation of Men's Health Platform
- Quarterly Activities/Appendix 4C Cash Flow Report
- EVE Completes Initial Production of Libbo
- EVE Signs Telehealth Services Agreement with hubMed -Revised
- EVE Signs Telehealth Services Agreement with hubMed
Later from EVE Health
- EVE Advances Reformulated Drugs Targeting Global Markets
- Trading Halt
- EVE Raises $0.9m to Advance Drug Reformulation Strategy
- EVE Placement Update
- Prospectus
Follow EVE Health into a list and get an email when it puts out news.
Follow EVE Health